REGISTRATION OBTAINED FOR AIRING™ IN UKRAINE

In the first quarter of 2024 marketing authorization was obtained in Ukraine for Airing™. Airing™ has been licensed from Mithra (Belgium) and is a generic version of Nuvaring™, a hormonal contraceptive vaginal ring. Market introductions are expected in the first and second half of 2024.

About Airing™

Airing™ (etonogestrel/ethinyl estradiol vaginal ring) is a non-biodegradable, flexible, transparent, combination contraceptive vaginal ring, with an outer diameter of 54 mm and a cross-sectional diameter of 4 mm. It is made of ethylene vinylacetate copolymers, and contains 11.7 mg etonogestrel and 2.7 mg ethinyl estradiol. When placed in the vagina, each ring releases, in line with the originator (Nuvaring®), on average 0.120 mg/day of etonogestrel and 0.015 mg/day of ethinyl estradiol over a three-week period of use. The ring is to remain in place continuously for three weeks. It is removed for a one-week break, during which a withdrawal bleed usually occurs. A new ring is inserted one week after the last ring was removed.
The availability of Airing™ gives for women in Ukraine access to a much improved, affordable and modern method of hormonal contraception. It is as effective as oral contraceptives, but has the advantages of better compliance and ease of use, with less side effects.